Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease

Neurotherapeutics - United States
doi 10.1007/s13311-016-0511-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC